Comparison of the efficacy of continuous intravenous infusion versus intramuscular injection of epinephrine for initial anaphylaxis treatment
- PMID: 36285105
- PMCID: PMC9585046
- DOI: 10.1002/ams2.790
Comparison of the efficacy of continuous intravenous infusion versus intramuscular injection of epinephrine for initial anaphylaxis treatment
Abstract
Aim: Continuous intravenous (CIV) infusion of epinephrine for the treatment of anaphylaxis may be required if symptoms do not improve after intramuscular (IM) injection. As CIV infusion permits precise dose adjustment, we compared treatment course and adverse events following CIV infusion and IM injection of epinephrine for the management of anaphylaxis.
Methods: Medical records of patients, who were treated for anaphylaxis with epinephrine, were 18 years or older, and were admitted to our department from April 2005 to March 2016, were retrospectively reviewed. The cases were categorized as CIV infusion or IM injection, and treatment course and outcomes were compared between the two groups.
Results: Of the 142 eligible cases, there were 78 in the CIV infusion group and 64 in the IM injection group. The CIV infusion group had lower systolic blood pressure, more respiratory symptoms, and higher Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, but required a lower total dose of epinephrine, had fewer adverse events after epinephrine administration, and showed lower incidence of biphasic reactions. In addition, compared with the IM injection group, time to administration of epinephrine was significantly longer (P < 0.001), but time to resolution of symptoms, both from contact and epinephrine administration, was significantly shorter (P < 0.01 and P = 0.03, respectively).
Conclusion: Continuous intravenous infusion of epinephrine for the treatment of anaphylaxis may be safe, has fewer adverse events, improves symptoms, and is relatively easy to administer under ready conditions. CIV infusion of epinephrine may also reduce the incidence of biphasic reactions.
Keywords: adverse event; anaphylaxis; biphasic reaction; epinephrine; intravenous infusion.
© 2022 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.
Figures


Similar articles
-
Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine.J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):76-80. doi: 10.1016/j.jaip.2014.06.007. Epub 2014 Aug 29. J Allergy Clin Immunol Pract. 2015. PMID: 25577622
-
Evaluating Practice Patterns of Observation Periods Following Epinephrine Administration for Anaphylaxis Among Pediatric Patients.Cureus. 2024 Sep 14;16(9):e69419. doi: 10.7759/cureus.69419. eCollection 2024 Sep. Cureus. 2024. PMID: 39403663 Free PMC article.
-
Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance Database.Int Arch Allergy Immunol. 2017;173(1):51-60. doi: 10.1159/000475498. Epub 2017 May 16. Int Arch Allergy Immunol. 2017. PMID: 28505618 Free PMC article.
-
Emerging Therapies in Anaphylaxis: Alternatives to Intramuscular Administration of Epinephrine.Curr Allergy Asthma Rep. 2021 Mar 5;21(3):18. doi: 10.1007/s11882-021-00994-0. Curr Allergy Asthma Rep. 2021. PMID: 33666759 Review.
-
Biphasic anaphylaxis: A review of the literature and implications for emergency management.Am J Emerg Med. 2018 Aug;36(8):1480-1485. doi: 10.1016/j.ajem.2018.05.009. Epub 2018 May 9. Am J Emerg Med. 2018. PMID: 29759531 Review.
Cited by
-
Epinephrine infusion as an adjuvant treatment for breakthrough reactions during desensitization to methotrexate.World Allergy Organ J. 2024 Sep 18;17(10):100965. doi: 10.1016/j.waojou.2024.100965. eCollection 2024 Oct. World Allergy Organ J. 2024. PMID: 39328211 Free PMC article. No abstract available.
-
Adrenaline Auto-Injectors for Preventing Fatal Anaphylaxis.Clin Exp Allergy. 2025 Jan;55(1):19-35. doi: 10.1111/cea.14565. Epub 2024 Oct 9. Clin Exp Allergy. 2025. PMID: 39383344 Free PMC article. Review.
-
Management of Refractory Anaphylaxis: An Overview of Current Guidelines.Clin Exp Allergy. 2024 Jul;54(7):470-488. doi: 10.1111/cea.14514. Epub 2024 Jun 12. Clin Exp Allergy. 2024. PMID: 38866583 Free PMC article. Review.
References
-
- Simons FER. Anaphylaxis. J. Aller. Clin. Immunol. 2010; 125: S161–81. - PubMed
-
- Soar J, Pumphrey R, Cant A et al. Emergency treatment of anaphylactic reactions—guidelines for healthcare providers. Resuscitation 2008; 77: 157–69. - PubMed
-
- Mink SN, Simons FE, Simons KJ, Becker AB, Duke K. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin. Exp. Allergy 2004; 34: 1776–83. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous